成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

8-Bromo-5-chloro-7-methylimidazo[1,2-c]pyrimidine

8-Bromo-5-chloro-7-methylimidazo[1,2-c]pyrimidine Struktur
2351094-67-0
CAS-Nr.
2351094-67-0
Englisch Name:
8-Bromo-5-chloro-7-methylimidazo[1,2-c]pyrimidine
Synonyma:
8-Bromo-5-chloro-7-methylimidazo[1,2-c]pyrimidine;Imidazo[1,2-c]pyrimidine, 8-bromo-5-chloro-7-methyl-
CBNumber:
CB95540474
Summenformel:
C7H5BrClN3
Molgewicht:
246.49
MOL-Datei:
2351094-67-0.mol

8-Bromo-5-chloro-7-methylimidazo[1,2-c]pyrimidine Eigenschaften

Sicherheit

8-Bromo-5-chloro-7-methylimidazo[1,2-c]pyrimidine Chemische Eigenschaften,Einsatz,Produktion Methoden

8-Bromo-5-chloro-7-methylimidazo[1,2-c]pyrimidine Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

8-Bromo-5-chloro-7-methylimidazo[1,2-c]pyrimidine Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 11)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Accela ChemBio Inc. 		+1-858-6993322
info@accelachem.com United States 17254 58
Chengdu Feibo Pharm Technology Co., Ltd +86 028-84641798 15982321820
 abby@arkpharm.com China 10925 58
Henan Alfachem Co.,Ltd. 0371-0371-55051623 18137891487
 2853979817@qq.com China 9873 58
Shanghai Yichang Chemical Co., Ltd. 13472573725
 sales@yichangchemical.com China 352 58
Beijing xinyanhui pharmaceutical research and development co., LTD 13969155946
 1461866103@qq.com China 16111 58
Accela ChemBio Co.,Ltd. 021-50795510 4000665055
 sales@accelachem.com China 11725 58
Shanghai Ruipu Medical Technology Co., Ltd 15895968936
 1018762393@qq.com China 9999 58
Established by Hangzhou Boman Biochem Tech Co., Ltd 13588048971 13588048971
 sales@bomanbiochem.com China 410 58
Bide Pharmatech Ltd. 400-1647117 13681763483
 product02@bidepharm.com China 62163 58
Shanghai Haohong Scientific Co., Ltd. 400-400-8210725
malulu@leyan.com China 39990 58
  • 8-Bromo-5-chloro-7-methylimidazo[1,2-c]pyrimidine
  • Imidazo[1,2-c]pyrimidine, 8-bromo-5-chloro-7-methyl-
  • 2351094-67-0
Copyright 2019 ? ChemicalBook. All rights reserved